SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-069427
Filing Date
2011-12-12
Accepted
2011-12-12 16:34:27
Documents
10
Period of Report
2011-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v241850_10q.htm 10-Q 989993
2 CERTIFICATION v241850_ex31-1.htm EX-31.1 14665
3 CERTIFICATION v241850_ex31-2.htm EX-31.2 14744
4 CERTIFICATION v241850_ex32.htm EX-32 7250
  Complete submission text file 0001144204-11-069427.txt   3135900

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnbt-20111031.xml EX-101.INS 311512
6 XBRL TAXONOMY EXTENSION SCHEMA gnbt-20111031.xsd EX-101.SCH 18737
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnbt-20111031_cal.xml EX-101.CAL 53664
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnbt-20111031_def.xml EX-101.DEF 85900
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnbt-20111031_lab.xml EX-101.LAB 189874
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnbt-20111031_pre.xml EX-101.PRE 108920
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 111256473
SIC: 2834 Pharmaceutical Preparations